Suprabasal spread of melanocytes in dysplastic nevi and melanoma in situ: Ki-67-labeling rate of junctional melanocytes and suprabasal cells may be a helpful clue to the diagnosis

American Journal of Surgical Pathology

Volumn 38, Issue 8, 2014, Pages 1111-1117

  Hall, Brian J ^a   Leboit, Philip E ^b  

^a St Alphonsus Hospital   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Dysplastic nevi; melanoma in situ; proliferation rate; suprabasal cells

Indexed keywords

KI 67 ANTIGEN; TUMOR MARKER;

ARTICLE; DIFFERENTIAL DIAGNOSIS; DYSPLASTIC NEVUS; FEMALE; HUMAN; MALE; MELANOCYTE; MELANOMA; METABOLISM; PATHOLOGY;

DIAGNOSIS, DIFFERENTIAL; DYSPLASTIC NEVUS SYNDROME; FEMALE; HUMANS; KI-67 ANTIGEN; MALE; MELANOCYTES; MELANOMA; TUMOR MARKERS, BIOLOGICAL;

EID: 84904547424     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0000000000000224     Document Type: Article

References (15)

1. Reimer RR, Clark WH Jr, Greene MH, et al. Precursor lesions in familial melanoma. A new genetic preneoplastic syndrome. JAMA. 1978;239:744-746.
2. Elder DE, Goldman LI, Goldman SC, et al. Dysplastic nevus syndrome: a phenotypic association of sporadic cutaneous melanoma. Cancer. 1980;46:1787-1794.
3. Farrahi F, Egbert BM, Swetter SM. Histologic similarities between lentigo maligna and dysplastic nevus: importance of clinicopathologic distinction. J Cutan Pathol. 2005;32:405-412
4. Erratum in: J Cutan Pathol. 2005;32(7):521.
5. Elder DE. Precursors to melanoma and their mimics: nevi of special sites. Mod Pathol. 2006;19(suppl 2):S4-20.
6. Khalifeh I, Taraif S, Reed JA, et al. A subgroup of melanocytic nevi on the distal lower extremity (ankle) shares features of acral nevi, dysplastic nevi, and melanoma in situ: a potential misdiagnosis of melanoma in situ. Am J Surg Pathol. 2007;31:1130-1136.
7. Coras B, Landthaler M, Stolz W, et al. Dysplastic melanocytic nevi of the lower leg: sex- and site-specific histopathology. Am J Dermatopathol. 2010;32:599-602.
8. Mooi WJ. The dysplastic naevus. J Clin Pathol. 1997;50:711-715. Review.
9. Roth ME, Grant-Kels JM, Ackerman AB, et al. The histopathology of dysplastic nevi. Continued controversy. Am J Dermatopathol. 1991;13:38-51. Review.
10. Arumi-Uria M. Dysplastic nevus: the eye of the hurricane. J Cutan Pathol. 2008;35(suppl 2):16-19. Review.
11. Shea CR, Vollmer RT, Prieto VG. Correlating architectural disorder and cytologic atypia in Clark (dysplastic) melanocytic nevi. Hum Pathol. 1999;30:500-505.
12. Pozo L, Naase M, Cerio R, et al. Critical analysis of histologic criteria for grading atypical (dysplastic) melanocytic nevi. Am J Clin Pathol. 2001;115:194-204.
13. Wick MR, Patterson JW. Cutaneous melanocytic lesions: selected problem areas. Am J Clin Pathol. 2005;124(suppl):S52-S83. Review.
14. Tronnier M, Smolle J, Wolff HH. Ultraviolet irradiation induces acute changes in melanocytic nevi. J Invest Dermatol. 1995;104: 475-478.
15. Mason AR, Mohr MR, Koch LH, et al. Nevi of special sites. Clin Lab Med. 2011;31:229-242. Review.